pqq cofactor has been researched along with Obesity in 3 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) is widespread in adults and children." | 1.46 | Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. ( Alfonso-Garcia, A; de la Houssaye, BA; DeFelice, BC; Fiehn, O; Florey, G; Friedman, JE; Heerwagen, MJ; Janssen, RC; Jonscher, KR; Jonscher, RL; Levi, M; Luo, Y; Potma, EO; Stewart, MS; Wang, XX; Wiitala, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Zhang, S | 1 |
| Hu, L | 1 |
| Wang, Y | 1 |
| Liu, K | 1 |
| Le, J | 1 |
| Tan, Y | 1 |
| Li, T | 1 |
| Xue, H | 1 |
| Wei, Y | 1 |
| Zhong, O | 1 |
| He, J | 1 |
| Zi, D | 1 |
| Lei, X | 2 |
| Deng, R | 1 |
| Luo, Y | 2 |
| Tang, M | 1 |
| Su, M | 1 |
| Cao, Y | 1 |
| Liu, Q | 1 |
| Tang, Z | 1 |
| Devasani, K | 1 |
| Kaul, R | 1 |
| Majumdar, A | 1 |
| Jonscher, KR | 1 |
| Stewart, MS | 1 |
| Alfonso-Garcia, A | 1 |
| DeFelice, BC | 1 |
| Wang, XX | 1 |
| Levi, M | 1 |
| Heerwagen, MJ | 1 |
| Janssen, RC | 1 |
| de la Houssaye, BA | 1 |
| Wiitala, E | 1 |
| Florey, G | 1 |
| Jonscher, RL | 1 |
| Potma, EO | 1 |
| Fiehn, O | 1 |
| Friedman, JE | 1 |
3 other studies available for pqq cofactor and Obesity
| Article | Year |
|---|---|
Pyrroloquinoline quinone inhibits PCSK9-NLRP3 mediated pyroptosis of Leydig cells in obese mice.
Topics: Animals; Humans; Inflammation; Leydig Cells; Male; Mice; Mice, Obese; NLR Family, Pyrin Domain-Conta | 2023 |
Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Blood Glucose; Cytokines; Disease Models, Animal; D | 2020 |
Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.
Topics: Animals; Antioxidants; Ceramides; Cyclooxygenase 2; Diet, High-Fat; Dietary Supplements; Female; Int | 2017 |